First Lady visits Haiti

Laura Bush was in Port-au-Prince, Haiti, last week, and she visited the GHESKIO HIV/AIDS clinic, which I linkurl:visited;http://www.the-scientist.com/2008/3/1/42/101/ this past January for an linkurl:article;http://www.the-scientist.com/2008/3/1/42/1/ on implementation research in our March issue. Bush was there drumming up support for linkurl:The United States President's Emergency Plan for AIDS Relief;http://www.pepfar.gov/ (PEPFAR), according to linkurl:__The Boston Globe__.;http://www.boston

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Laura Bush was in Port-au-Prince, Haiti, last week, and she visited the GHESKIO HIV/AIDS clinic, which I linkurl:visited;http://www.the-scientist.com/2008/3/1/42/101/ this past January for an linkurl:article;http://www.the-scientist.com/2008/3/1/42/1/ on implementation research in our March issue. Bush was there drumming up support for linkurl:The United States President's Emergency Plan for AIDS Relief;http://www.pepfar.gov/ (PEPFAR), according to linkurl:__The Boston Globe__.;http://www.boston.com/news/health/articles/2008/03/14/first_lady_visits_haitian_aids_clinic/ President George Bush started PEPFAR in 2003, dedicating $15 billion to the effort over five years. Last Thursday, the Senate Foreign Relations Committee linkurl:approved;http://biden.senate.gov/newsroom/details.cfm?id=294768&& legislation that boosts PEPFAR's budget to $50 billion and extends the program for another five years. When I was in Haiti, I learned that a lot of the antiretroviral drugs that GHESKIO dispenses linkurl:free of charge;http://www.the-scientist.com/2008/3/1/42/100/ to Haitian HIV/AIDS patients are bought with PEPFAR money. __The Globe__ reported that the First Lady "barely set foot outside a car or building during the tightly managed trip," while in Port-au-Prince, which is understandable given the still-precarious security situation in Haiti's capital - especially in the neighborhoods surrounding the GHESKIO center.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours